非奈利酮进医保了吗能报销吗?

Is fenelidone included in medical insurance?

Fennelidone can be used to treat diabetic nephropathy, chronic kidney disease and end-stage renal disease. It can reduce proteinuria in patients and increase the glomerular filtration rate. Fenelidone will be approved for marketing by the US FDA in July 2021, and will be approved by China's NMPA in June 2022. Since fenelidone has been on the market for a short time in China, it is not yet included in medical insurance and cannot be reimbursed by medical insurance.

The price of fenelidone overseas drugs

Fenelidone is already available in overseas markets. It is understood that overseas drugs are affected by exchange rate fluctuations, and drug prices are not fixed. The specific reference prices are as follows:

The specifications of the Bangladesh Everest version of Fenelidone (Keshenda) are 10mg*10 tablets, and the price is about 370 per box.

Bayer exports the Japanese version of Fenelidone (Keshenda) in specifications: 20mg*100 tablets, the price is about 8500 per box, the specification is 10mg*100 tablets, the price is about 7500 per box;

The price of the US version of Fenelidone in 10 mg*30 tablets is about $6,300, and in the US version of 20 mg*30 tablets, the price is about $6,500;

Patients who need fenelidone can choose the medicine according to their own situation. They can buy it from domestic hospital pharmacies, but the cost of imported medicine is relatively high. Patients can also obtain it through domestic professional overseas medical service institutions, and the medicine can be directly mailed to their homes from overseas. This ensures that the medicine is genuine and also avoids patients from traveling internationally. Moreover, it is more cost-effective to obtain drugs through domestic professional overseas medical service institutions, but it is recommended to consult customer service personnel for specific costs and drug purchase procedures, so that drug purchase is more secure.

Finelidone is a non-steroidal drug that reduces fluid retention and reduces the load on the kidneys and heart by acting on the renal tubules. The MR receptors in the tissues are blocked, thus inhibiting organ damage. It can selectively block the mineralocorticoid (MR) receptors present in the renal tubules and tissues. It is recommended that patients take medication under the guidance of a doctor and receive symptomatic treatment.

Recommended related articles: